The scale of genomics sequencing projects continues to grow rapidly. Just as the 1,000 Genomes Project once dwarfed the Human Genome Project, now an initiative involving Amazon, Baylor College of Medicine and DNAnexus has surpassed both of them, generating 430 terabytes of data in the process.
CSC, known in Britain for its role in a health IT fiasco, has helped pharmaceutical distributors and other companies migrate to the cloud.
Veeva Systems has filed paperwork as expected to raise up to $150 million in an initial public offering. The fast-growing provider of cloud-based software for sales groups in life sciences would like to list its shares on the New York Stock Exchange under the symbol "VEEV."
In an InformationWeek profile, GlaxoSmithKline touts the benefits of a new online collaboration system, including the savings on travel expenses and satisfaction of the pharma giant's customers.
Accelrys ($ACCL) has added to a string of acquisitions in recent years with the buyout of ChemSW, a provider of software for companies in pharma and other sectors to ditch paper-based systems for managing chemical inventories.
Reports of Chinese hackers and U.S. National Security Agency (NSA) snooping have raised fresh doubts about the security of the ever increasing amounts of data kept in the cloud. Google--which was implicated in the NSA revelations--has responded by beefing up its cloud storage service.
Bioinformatics startup InterpretOmics has snagged $1.6 million (Rs 10 crore) from a slate of angel backers, seeking to grow its business of providing cloud-based software for analyzing genomics data, the company said last week. The only named investor was the Singapore-based shipping company Amarante.
Assay Depot, which has created an Amazon-like service for buying research services, has landed drug giant Pfizer as a new customer. Pfizer has adopted the San Diego-based startup's enterprise software that allows its scientists to peruse the services of thousands of CROs.
Medidata Solutions is scheduled to close on a $287.5 million notes offering Monday, giving the company a surplus of money in the bank to finance potential acquisitions and other business activities and more than doubling the company's reserves.
Daiichi Sankyo, a Japan-based pharma heavyweight, has chosen Medidata's cloud software for the group's clinical trials in China, expanding its long-time customer relationship with the New York-based company.